Health Care Sector
895 health care stocks ranked by market capitalization, page 7 of 18. Updated October 11, 2026.
Today
+1.52%Health Care stocks ranked 301–350
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 301 | PNTG | The Pennant Group Inc. | 39.73 | -1.59% | 321.43K | $1.39B |
| 302 | AGL | agilon health inc. | 82.39 | -2.75% | 171.88K | $1.38B |
| 303 | AAPG | Ascentage Pharma Group International American Depository Shares | 14.75 | +1.37% | 1.18K | $1.38B |
| 304 | ANAB | AnaptysBio Inc. | 45.95 | -0.56% | 495.67K | $1.37B |
| 305 | KARD | Kardigan Inc. | 14.67 | +3.31% | 740.19K | $1.37B |
| 306 | TYRA | Tyra Biosciences Inc. | 19.94 | -0.15% | 649.44K | $1.37B |
| 307 | HLF | Herbalife Ltd. | 13.03 | +1.64% | 1.49M | $1.35B |
| 308 | DRTS | Alpha Tau Medical Ltd. | 14.41 | +2.93% | 368.20K | $1.33B |
| 309 | CNMD | CONMED Corporation | 44.42 | -1.53% | 400.45K | $1.33B |
| 310 | OMDA | Omada Health Inc. | 21.55 | +3.51% | 836.76K | $1.32B |
| 311 | EYE | National Vision Holdings Inc. | 16.68 | -0.36% | 975.65K | $1.32B |
| 312 | DMRA | Damora Therapeutics Inc. | 21.08 | +2.53% | 368.73K | $1.30B |
| 313 | REPL | Replimune Group Inc. | 13.42 | +2.91% | 2.02M | $1.26B |
| 314 | USPH | U.S. Physical Therapy Inc. | 84.67 | +1.38% | 143.47K | $1.26B |
| 315 | ORIC | Oric Pharmaceuticals Inc. | 11.99 | -0.33% | 1.09M | $1.24B |
| 316 | INNV | InnovAge Holding Corp. | 9.10 | -0.11% | 343.09K | $1.24B |
| 317 | NBTX | Nanobiotix S.A. ADR | 23.68 | +3.41% | 93.50K | $1.21B |
| 318 | LBRX | LB Pharmaceuticals Inc | 37.22 | +7.54% | 642.29K | $1.20B |
| 319 | CRON | Cronos Group Inc. | 3.23 | +0.31% | 414.05K | $1.19B |
| 320 | VOR | Vor Biopharma Inc. | 19.90 | +4.03% | 1.10M | $1.18B |
| 321 | BCAX | Bicara Therapeutics Inc. | 17.50 | +1.39% | 715.97K | $1.16B |
| 322 | AVLN | Avalyn Pharma Inc. | 25.76 | +0.16% | 241.84K | $1.14B |
| 323 | TRAX | First Tracks Biotherapeutics Inc. | 31.85 | -0.50% | 855.24K | $1.14B |
| 324 | TRUP | Trupanion Inc. | 26.06 | +0.93% | 269.94K | $1.14B |
| 325 | AMPH | Amphastar Pharmaceuticals Inc. | 26.62 | +3.14% | 437.70K | $1.13B |
| 326 | IMTX | Immatics N.V. | 7.43 | +0.81% | 1.37M | $1.13B |
| 327 | JANX | Janux Therapeutics Inc. | 18.39 | -0.59% | 1.17M | $1.12B |
| 328 | TNDM | Tandem Diabetes Care Inc. | 16.11 | +2.78% | 1.43M | $1.12B |
| 329 | IRMD | iRadimed Corporation | 87.45 | +1.83% | 68.87K | $1.12B |
| 330 | HROW | Harrow Inc. | 29.36 | -3.80% | 1.35M | $1.10B |
| 331 | STAA | STAAR Surgical Company | 21.67 | -3.17% | 592.50K | $1.09B |
| 332 | LTGO | Latigo Biotherapeutics Inc. | 16.00 | +8.18% | 184.22K | $1.06B |
| 333 | MNKD | MannKind Corporation | 3.29 | -3.80% | 4.55M | $1.06B |
| 334 | CSTL | Castle Biosciences Inc. | 34.42 | +2.11% | 249.08K | $1.05B |
| 335 | CDRE | Cadre Holdings Inc. | 24.55 | -1.13% | 877.05K | $1.05B |
| 336 | TDOC | Teladoc Health Inc. | 5.77 | +4.15% | 4.18M | $1.05B |
| 337 | PRCT | PROCEPT BioRobotics Corporation | 18.40 | +2.79% | 1.11M | $1.05B |
| 338 | IART | Integra LifeSciences Holdings Corporation | 13.44 | +0.22% | 1.23M | $1.05B |
| 339 | AORT | Artivion Inc. | 21.26 | +0.24% | 343.00K | $1.04B |
| 340 | OPK | OPKO Health Inc. | 1.38 | +0.73% | 1.09M | $1.03B |
| 341 | MGTX | MeiraGTx Holdings plc | 10.69 | +1.81% | 523.43K | $1.03B |
| 342 | ENOV | Enovis Corporation | 17.69 | +1.49% | 1.13M | $1.02B |
| 343 | LMRI | Lumexa Imaging Holdings Inc. | 10.54 | +2.03% | 370.85K | $1.01B |
| 344 | SVRA | Savara Inc. | 4.92 | +1.86% | 1.53M | $1.01B |
| 345 | AKTS | Aktis Oncology Inc. | 18.15 | +2.31% | 361.04K | $1.01B |
| 346 | PIII | P3 Health Partners Inc. Class A | 4.95 | -6.78% | 10.07K | $1.01B |
| 347 | ANL | Adlai Nortye Group Ltd. ADR | 15.62 | +0.71% | 300.44K | $1.01B |
| 348 | SPTX | Seaport Therapeutics Inc. | 18.15 | +1.34% | 171.21K | $971.58M |
| 349 | ANRO | Alto Neuroscience Inc. | 24.37 | +1.41% | 649.43K | $956.33M |
| 350 | CGEM | Cullinan Therapeutics Inc. | 15.53 | +0.45% | 567.53K | $954.44M |
Prices as of Oct 11, 3:40 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer